SUMMARY The association of non-random chromosome abnormalities with solid tumours of childhood may improve accuracy of diagnosis and prognosis and lead to a better understanding of their biology. In a pilot study in the Northern region of England fresh tumour biopsy specimens were obtained from 39 of 72 consecutive solid tumours in children who presented over a period of 21 months. Cytogenetic analysis was possible in 33 and clonal chromosomal abnormalities were detected in nine. In addition, seven of 10 tumours investigated after treatment were abnormal. Ten of these 16 abnormal karyotypes have not previously been described. This pilot study has shown that a concerted investigation of tumour cytogenetics is possible. A multicentre study is essential if our knowledge of basic tumour cytogenetics is to progress.
Despite our ability to achieve prolonged remissions in most children with cancer, malignant disease remains second only to birth defects as the most common non-accidental cause of death in children over the age of 1 year in the United Kingdom. Accurate diagnosis is essential in order that appropriate treatment is used, but even within any one tumour category there remain variations in behaviour and response to treatment.
In the leukaemias some clonal cytogenetic abnormalities have already proved to be of diagnostic and prognostic value. For example, the translocations t(9;22), t(8;21), t(15;17), and t (8;14) help towards the diagnosis of chronic myeloid, acute myeloblastic, acute promyelocytic, and Burkitt's leukaemia respectively,' and clonal structural abnormalities are associated with a poor outcome in acute lymphoblastic leukaemia of childhood.2 Studies of the oncogene c-abl in chronic myeloid leukaemia3 and the relationship between c-myc and immunoglobulin gene loci in Burkitt's lymphoma4 have led to a rapid increase in our knowledge of the molecular biology of haemopoietic malignancy.
Although clonal cytogenetic abnormalities have been reported in some solid tumours of children, much of the published information has appeared as single case reports. Cytogenetic investigations of solid tumours lag far behind those of leukaemias due to a combination of reasons including technical problems and the relative difficulty in obtaining viable tumour cells. One of the early steps in understanding the biology of malignancy, however, is to obtain a detailed knowledge of non-random chromosomal abnormalities of tumour cells. If the analogy with leukaemia is appropriate, then cytogenetic studies of solid tumours could provide diagnostic and prognostic information and the basis for a detailed study of the molecular events associated with their genesis.
In order that this baseline knowledge can be obtained a vigorous and comprehensive effort to study the chromosomes of all childhood solid tumours is required. We have embarked on a pilot study to obtain fresh material from most childhood solid tumours in the Northern region and carry out cytogenetic studies on these specimens. This report describes our initial results. None the less, the cytogenetic abnormalities found in cells from a heavily pretreated neuroblastoma primary tumour,0 bone marrow metastases from another, and spinal fluid seedlings from a relapsed medulloblastoma are characteristic of those in untreated tumours.7 Also two of the clones (B and C) from a relapsed ependymoma (data not in table) resemble the abnormalities described in the only other published G banded case of this disease. 8 In all other cases, apart from the two remaining disseminated neuroblastomas, the abnormalities we have found have not previously been described. Of This series of karyotypes highlights the current state of knowledge of cytogenetic abnormalities of solid tumours of childhood; each case constitutes a significant contribution to our knowledge. Although karyotypic abnormalities are being reported increasingly at international scientific meetings, most are published only as abstracts. Some patterns have begun to emerge. In retinoblastoma, isochromosome 6p appears to be a unique abnormality,"1 and the one case of retinoblastoma in the present series also had an abnormality of chromosome 6. Alveolar rhabdomyosarcomas are associated with t(2;13), 12 and evidence suggests that 3p 14 -> 21 may be a non-random site for change in this disease. 
Methods

